9999国产精品欧美久久久久久 ,欧美成人怡红院一区二区

狠狠综合久久久久综合网,亚州少妇无套内射激情视频,成年免费A级毛片免费看丶,欧美熟妇色ⅩXXX欧美妇

鄭重說明:

您值得信賴的中藥成分及標(biāo)準(zhǔn)合作伙伴滿足您研發(fā)和工業(yè)化需求

產(chǎn)品關(guān)鍵詞：香草酸-4-β-D-葡萄糖苷 6-甲氧基山奈酚茯苓新酸B 去甲異波爾定

guanyuwomen關(guān)于德思特

聯(lián)系方式

服務(wù)熱線：

028-8500-3950

公司傳真：	028-85589956
公司郵箱：	sales@tcmlmt.com
公司網(wǎng)址：	usemark.cn
公司地址：	四川省成都市溫江區(qū)?？坡肺鞫?28號5棟

發(fā)表文獻(xiàn)展示

當(dāng)前位置:首頁關(guān)于德思特 > 發(fā)表文獻(xiàn)展示 >

The Journal of Supercritical Fluids-26 August 2019 藤黃酸

時間：2020-09-03 瀏覽次數(shù)：分享到：

Solubility measurement and RESOLV-assisted nanonization of gambogic acid in supercritical carbon dioxide for cancer therapy
期刊名：The Journal of Supercritical Fluids
文獻(xiàn)編號：DOI 10.1016/j.supflu.2019.04.008
文獻(xiàn)地址：https://www.sciencedirect.com/science/article/pii/S0896844619300658?via%3Dihub
發(fā)表日期：26 August 2019

Abstract
Despite the captivating interest for its potential anticancer efficacy against multiple types of cancer and ability to overcome multidrug resistance, the practical application of gambogic acid (GA) has been hampered by its poor water solubility. Herein, the fabrication of nanosized GA particles (251.2 nm ± 85.6 nm) using eco-friendly supercritical fluid (SCF)-assisted rapid expansion of a supercritical solution into a liquid solvent (RESOLV) process was demonstrated. The equilibrium solubility of GA in supercritical carbon dioxide (SC−CO2) was initially determined at altered supercritical conditions (P: 10.0 MPa to 30.0 MPa, T: 308.15 K–328.15 K) and the obtained data points were then correlated using various density-based models including Méndez-Santiago and Teja, Bartle as well as Chrastil models. The solubility of GA in SC−CO2 was found to be between 1.63 × 10−6 and 22.62 × 10−6 in terms of GA mole fraction, and considerably good correlation agreement was obtained with all the applied models and being the lowest deviations obtained with the Méndez-Santiago and Teja model. Furthermore, the fabricated GA nanoparticles (NPs) through benign RESOLV technique, were systematically characterized. Subsequently, in vitro antiproliferation tests resulted in its augmented antitumor efficacy due to enhanced solubility of GA. Together, the results have suggested that the benign RESOLV process has successfully fabricated nanosuspensions of GA with enhanced bioavailability and antineoplastic efficacy and may have great potential in pharmaceutics.

gambogic acid was purchased from DeSiTe Biological Technology Co. Ltd. (Chengdu, China)

上一篇：Royal Society of Chemistry-12 Aug 2019 圣草次苷

下一篇：Molecules-23 July 2019 半齒澤蘭素